TNF inhibitors (TNFi), used to treat patients with juvenile idiopathic arthritis (JIA), do not only dampen inflammation, but they have been shown to also inhibit the germinal center response and, thus, to decrease the frequency of MBCs. Here, TNF is linked to juvenile idiopathic arthritis.